Načítá se...
Survival of the fittest: in vivo selection and stem cell gene therapy
Stem cell gene therapy has long been limited by low gene transfer efficiency to hematopoietic stem cells. Recent years have witnessed clinical success in select diseases such as X-linked severe combined immunodeficiency (SCID) and ADA deficiency. Arguably, the single most important factor responsibl...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
© 2006 by The American Society of Hematology
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1895696/ https://ncbi.nlm.nih.gov/pubmed/16269617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2005-06-2335 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|